These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20231554)

  • 21. ACP Journal Club. Review: oral phosphodiesterase 4 inhibitors reduce exacerbations but increase adverse events in COPD.
    Ram FS
    Ann Intern Med; 2011 Sep; 155(6):JC3-2. PubMed ID: 21930839
    [No Abstract]   [Full Text] [Related]  

  • 22. ACP Journal Club: review: dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes.
    Chatterjee S; Chatterjee S
    Ann Intern Med; 2013 Apr; 158(8):JC8. PubMed ID: 23588773
    [No Abstract]   [Full Text] [Related]  

  • 23. ACP Journal Club: review: varenicline for tobacco cessation does not increase CV serious adverse events.
    Krebs P; Sherman SE
    Ann Intern Med; 2012 Aug; 157(4):JC2-2. PubMed ID: 22910956
    [No Abstract]   [Full Text] [Related]  

  • 24. ACP Journal Club. Review: Dopamine agonists are effective for the restless legs syndrome but may be discontinued due to adverse events.
    Andolsek KM
    Ann Intern Med; 2011 Jul; 155(2):JC1-9. PubMed ID: 21768575
    [No Abstract]   [Full Text] [Related]  

  • 25. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-type natriuretic Peptide as a predictor of postoperative cardiopulmonary complications in elderly patients undergoing pulmonary resection for lung cancer.
    Nojiri T; Inoue M; Yamamoto K; Maeda H; Takeuchi Y; Funakoshi Y; Okumura M
    Ann Thorac Surg; 2011 Sep; 92(3):1051-5. PubMed ID: 21871299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-terminal pro-B-type natriuretic peptide with fractional excretion and clearance of sodium in relation to cardiovascular events after elective cervical spine surgery.
    Spatenkova V; Bradac O; Kazda A; Suchomel P
    Neuro Endocrinol Lett; 2011; 32(6):874-8. PubMed ID: 22286795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACP Journal Club. Review: omega-3 polyunsaturated fatty acid supplements do not reduce major cardiovascular events in adults.
    Smith DA
    Ann Intern Med; 2012 Dec; 157(12):JC6-5. PubMed ID: 23247954
    [No Abstract]   [Full Text] [Related]  

  • 30. ACP Journal Club. Review: biologic agents increase short-term risk for some adverse events in conditions other than HIV or AIDS.
    Schattner A
    Ann Intern Med; 2012 May; 156(10):JC5-9. PubMed ID: 22586027
    [No Abstract]   [Full Text] [Related]  

  • 31. Preoperative cardiovascular evaluation for noncardiac surgery.
    Maddox TM
    Mt Sinai J Med; 2005 May; 72(3):185-92. PubMed ID: 15915313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACP Journal Club. Review: Statins are effective for prevention of cardiovascular events in patients without coronary heart disease.
    McAlister FA
    Ann Intern Med; 2009 Apr; 150(8):JC4-5. PubMed ID: 19391211
    [No Abstract]   [Full Text] [Related]  

  • 33. A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients.
    Rodseth RN; Padayachee L; Biccard BM
    Anaesthesia; 2008 Nov; 63(11):1226-33. PubMed ID: 18673363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACP Journal Club. Review: Inhaled anticholinergics increase risk for major cardiovascular events in chronic obstructive pulmonary disease.
    Stanbrook MB
    Ann Intern Med; 2009 Jan; 150(2):JC1-6, JC1-7. PubMed ID: 19172711
    [No Abstract]   [Full Text] [Related]  

  • 35. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
    Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
    J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain natriuretic peptide levels predict perioperative events in cardiac patients undergoing noncardiac surgery: a prospective study.
    Leibowitz D; Planer D; Rott D; Elitzur Y; Chajek-Shaul T; Weiss AT
    Cardiology; 2008; 110(4):266-70. PubMed ID: 18073483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-operative cardiac risk assessment in noncardiac surgery: are natriuretic peptides the magic bullet?
    Bolliger D; Seeberger MD; Filipovic M
    J Am Coll Cardiol; 2009 Oct; 54(17):1607-8. PubMed ID: 19833259
    [No Abstract]   [Full Text] [Related]  

  • 38. Is brain natriuretic peptide a marker for adverse postoperative outcomes in patients undergoing cardiac surgery?
    Mitchell J; Webb ST
    Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):467-72. PubMed ID: 21186284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery.
    Kulier A; Levin J; Moser R; Rumpold-Seitlinger G; Tudor IC; Snyder-Ramos SA; Moehnle P; Mangano DT; ;
    Circulation; 2007 Jul; 116(5):471-9. PubMed ID: 17620512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.